Quantcast
Last updated on April 18, 2014 at 16:08 EDT

Latest Biosafe Group Stories

2014-04-08 08:30:14

EYSINS, Switzerland, April 8, 2014 /PRNewswire/ -- Biosafe is proud to report that it has just received the official registration of its single use disposable kits with the Chinese FDA. Following earlier approval of the Company's Sepax cell processing machine, Biosafe is now primed to launch sales of its products in the People's Republic of China. (Logo: http://photos.prnewswire.com/prnh/20140407/679480 ) Olivier Waridel, CEO of the Biosafe Group...

2013-10-28 08:28:29

EYSINS, Switzerland, October 28, 2013 /PRNewswire/ -- Biosafe is pleased to report the launch of its new Smart-Max device at the ESH World Cord Blood Congress in Monaco last week. (Logo: http://photos.prnewswire.com/prnh/20131028/648200 ) The Smart-Max device has multiple areas of application in cell processing, including cell mixing, cooling, thawing, dilution, incubation and digestion. It is fully automated with an easy-to-use touchscreen interface and can...

2013-09-23 08:28:03

EYSINS, Switzerland, September 23, 2013 /PRNewswire/ -- Biosafe is pleased to announce that, in partnership with its Indian Distributor Span Healthcare Private Ltd., it has achieved major expansion of its stem cell banking business in India, winning major new customer deals consecutively. In the public stem cell banking area, Jeevan Blood Bank and Research Centre in Chennai is expanding its program and will process its full volume of stem cell samples with Biosafe's...

2013-03-11 04:20:48

EYSINS, Switzerland, March 11, 2013 /PRNewswire/ -- Biosafe is proud to announce that it is celebrating a landmark, with the manufacture of the one millionth proprietary SEPAX separation chamber for cord blood processing kits. This milestone confirms that SEPAX has become the industry standard in cord blood banking, as it has been used in almost half of worldwide processing procedures for cord blood inventory. (Logo: http://photos.prnewswire.com/prnh/20121119/574143 )...

2011-06-29 11:23:00

COVINA, Calif., June 29, 2011 /PRNewswire/ -- California-based StemCyte, Inc. continues its innovative leadership in cord blood banking and cell therapies with the announcement of Dual Processing Capabilities using the Sepax automation system from Biosafe, a world leader in stem cell processing. StemCyte will begin enhancing its cord blood product inventory by processing and banking UCB product via both its "plasma depletion" method as well as the "red cell reduction" method. This added...